Pleuroparenchymal Fibroelastosis Lesion in Explanted Lungs of a Patient with Fibrotic Pulmonary Sarcoidosis.

Intern MedFeb 1, 2026 (epub)

Masato Kono, Takahiko Saito, Takuma Sugiura et al.

✦ AI-curated · Sources linked

Case in brief

A 59-year-old woman with long-standing pulmonary sarcoidosis developed progressive upper-lobe-predominant fibrosis and cystic changes, ultimately undergoing living-donor lung transplantation. Examination of the explanted lungs showed pleural thickening and subpleural intra-alveolar fibroelastosis consistent with pleuroparenchymal fibroelastosis (PPFE). Typical granulomatous lesions of sarcoidosis were absent in the examined tissue.

What made this case unusual

Histopathology identified PPFE in a patient with fibrotic pulmonary sarcoidosis, despite the absence of typical granulomatous lesions in the explanted lungs.

Diagnostic / clinical pearl

In progressive upper-lobe-predominant fibrosis associated with sarcoidosis, explant histopathology may reveal PPFE even when typical granulomas are absent.

Why it matters

The case provides pathological evidence supporting PPFE as a possible fibrotic manifestation of end-stage pulmonary sarcoidosis.

Source

Published in Intern Med. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pulmonology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.